CN106674085B - Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound - Google Patents

Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound Download PDF

Info

Publication number
CN106674085B
CN106674085B CN201611183379.XA CN201611183379A CN106674085B CN 106674085 B CN106674085 B CN 106674085B CN 201611183379 A CN201611183379 A CN 201611183379A CN 106674085 B CN106674085 B CN 106674085B
Authority
CN
China
Prior art keywords
compound
aminopiperidine
base
synthesizing
difluoroisopropyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201611183379.XA
Other languages
Chinese (zh)
Other versions
CN106674085A (en
Inventor
茅仲平
马东旭
葛永辉
任雪景
李大鹏
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Changshu Hongde Biotechnology Co.,Ltd.
Original Assignee
SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY CO LTD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY CO LTD filed Critical SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY CO LTD
Priority to CN201611183379.XA priority Critical patent/CN106674085B/en
Publication of CN106674085A publication Critical patent/CN106674085A/en
Application granted granted Critical
Publication of CN106674085B publication Critical patent/CN106674085B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/56Nitrogen atoms
    • C07D211/58Nitrogen atoms attached in position 4

Abstract

The invention discloses a synthesis method of an N-1, 3-difluoro isopropyl-4-aminopiperidine compound, and particularly relates to a target compound N-1, 3-difluoro isopropyl-4-aminopiperidine compound which is obtained by taking 1, 3-difluoro propane-2-alcohol as a raw material through two-step reaction. The method has the advantages of simple raw materials, low cost, easy obtainment, simple reaction conditions and high chemical purity of the obtained product.

Description

Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound
Technical Field
The invention relates to a synthetic method of an organic drug intermediate, in particular to a synthetic method of an N-1, 3-difluoro isopropyl-4-aminopiperidine compound.
Background
4-aminopiperidine is an important pharmaceutical intermediate. Is mainly used for synthesizing and producing drugs for preventing or treating various pains such as postoperative pain, migraine, visceral pain, neuropathic pain and the like and symptoms such as addiction, tolerance and the like caused by analgesic drugs such as opioid.
Fluorine-containing compounds have occupied a considerable specific gravity among the drugs on the market in recent years. Pharmaceutical chemists increasingly recognize that selective introduction of fluorine atoms or fluorine-containing groups into organic compounds can bring subtle changes to their biological effects, and thus, how to introduce fluorine atoms into compounds has become a hot research topic. The synthesis of tert-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate has not been reported so far. A known method is the synthetic method reported in patent PCT int.appl., 2012049277. The method takes 1, 3-difluoropropane-2-ketone as a raw material to react with tert-butyl piperidine-4-carbamate to generate tert-butyl- (1- (1, 3-difluoropropane-2-yl) piperidine-4-yl) carbamate. The method has high cost, needs a reagent with low atom economy such as sodium borohydride acetate, is not environment-friendly, is not easy to operate and has low yield.
Disclosure of Invention
The invention aims to solve the technical problem of providing a synthetic method of an N-1, 3-difluoro isopropyl-4-aminopiperidine compound, which has short synthetic route, can effectively control the cost and improve the economic benefit.
In order to solve the technical problems, the invention adopts the technical scheme that:
a compound having the following general formula I: a method for synthesizing N-1, 3-difluoro isopropyl-4-amino piperidine compounds,
Figure BDA0001185618860000011
the method comprises the following steps: (1) dissolving 1, 3-difluoropropane-2-ol and alkali A in a solvent A, then dropwise adding methanesulfonyl chloride, and separating to obtain 1, 3-difluoropropane-2-yl-methanesulfonic acid;
(2) dissolving the compound of the general formula II in a solvent B, adding an alkali B, heating for reaction,
Figure BDA0001185618860000021
after the reaction is finished, separating and purifying to obtain the N-1, 3-difluoro isopropyl-4-aminopiperidine compound, wherein R is1,R2Each independently selected from: hydrogen, tert-butoxycarbonyl, C1-C8 alkyl, 3-methylbutyl, benzyl, 3-methyl-2-en-1-yl, 2-methoxyethyl, 2-ethylbutyl, hexyl, octyl, 2-dimethylaminoethyl, 3-dimethylaminopropyl, cyclopropylmethyl, 2-cyclopropylethyl, 2-pyrroethyl, 2- (N-ethylpyrrol-2-yl) -ethyl, cyclopentyl, cyclohexyl, 3, 4-dimethoxyphenethyl.
Preferably, R1,R2Each independently selected from: hydrogen, tert-butoxycarbonyl.
Preferably, the base A is an organic base, and the base B is an inorganic base.
Preferably, the base A is triethylamine, and the base B is potassium carbonate or sodium carbonate.
Preferably, the solvent A is dichloromethane, and the solvent B is dimethyl sulfoxide.
Preferably, the volume weight ratio (ml/g) of the dichloromethane to the 1, 3-difluoropropan-2-ol is 3-10: 1; the volume-to-weight ratio (ml/g) of the dimethyl sulfoxide to the compound of the general formula II is 3-10: 1.
preferably, the molar ratio of the added amount of the methane sulfonyl chloride to the 1, 3-difluoropropane-2-ol is 0.5-2.5: 1; the molar ratio of the added 1, 3-difluoropropane-2-ol to the compound of the general formula II is 0.5-2.5: 1.
the term "alkyl" in the present invention includes straight-chain and branched alkyl groups such as methyl, ethyl, propyl, isopropyl, butyl, isobutyl, sec-butyl, pentyl, 2-ethyl-butyl, hexyl, heptyl, octyl and the like;
the term "t-butyloxycarbonyl" as used herein refers to a Boc substituent.
The starting materials used in the present invention are either commercially available or synthesized using methods well known in the art.
The invention achieves the following beneficial effects:
the synthetic method of the invention does not need special production equipment and does not have (extremely) low-temperature operation; and can provide high-purity products (not less than 97 percent), thereby obtaining higher economic benefits; for some products, the method uses low-cost raw materials, has low cost and high yield, and the raw materials are easy to obtain.
Drawings
FIG. 1 is a synthesis scheme for the product of example 1.
Detailed Description
The invention is further described below with reference to the accompanying drawings. The following examples are only for illustrating the technical solutions of the present invention more clearly, and the protection scope of the present invention is not limited thereby.
Example 1
As shown in fig. 1: a method for synthesizing tert-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate, comprising the following steps:
dissolving raw materials 1, 3-difluoropropane-2-ol and triethylamine in dichloromethane, and dropwise adding methane sulfonyl chloride into the solution at zero degree. After dropping, the mixture was stirred at zero degrees centigrade for one hour, and then warmed to room temperature and stirred for one hour until the reaction was complete. Pouring the reaction mixture into an ice water solution, separating, extracting by dichloromethane, washing an organic layer by using one mole of hydrochloric acid at zero degree until the pH value is 2-3, washing the organic layer by using water, washing the organic layer by using a saturated sodium bicarbonate aqueous solution at zero degree until the pH value is 8-9, washing the organic layer by using water, drying the organic layer by using anhydrous sodium sulfate, and concentrating under reduced pressure to obtain the 1, 3-difluoropropan-2-yl-methane sulfonic acid.
Dissolving a raw material piperidine-4-carbamic acid tert-butyl ester in dimethyl sulfoxide, adding 1, 3-difluoropropane-2-yl-methane sulfonic acid and potassium carbonate, and heating to one hundred twenty ℃ until the reaction is complete. After cooling to room temperature, the reaction mixture was poured into water, extracted with ethyl acetate, and the organic layer was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to obtain tert-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate.
Wherein, the used raw materials of piperidine-4-carbamic acid tert-butyl ester and 1, 3-difluoropropane-2-alcohol are commercially available chemicals, have low price and can be conveniently obtained.
Example 2
28.8 g of 1, 3-difluoropropan-2-ol, 60.6 g of triethylamine and 300 ml of dichloromethane are added into a three-neck reaction bottle with a stirrer, 41.2 g of methanesulfonyl chloride is added dropwise at zero centigrade, the mixture is stirred at zero centigrade for one hour, then the stirring is continued for one hour at room temperature, the reaction mixture is poured into 200 ml of ice water solution, dichloromethane is used for extraction (100 ml of × 2) at zero centigrade, one mol of hydrochloric acid is used for washing an organic layer until the pH value is 2-3, an organic layer is washed with water (100 ml), saturated sodium bicarbonate aqueous solution is used for washing the organic layer at zero centigrade until the pH value is 8-9, the organic layer is washed with water (100 ml), the organic layer is dried by anhydrous sodium sulfate and concentrated under reduced pressure to obtain 43 g of 1, 3-difluoropropan-2-yl-methanesulfonic acid, the yield is 86%, and the purity is 98%.
54 g of raw material piperidine-4-carbamic acid tert-butyl ester is dissolved in 500 ml of dimethyl sulfoxide, 43 g of 1, 3-difluoropropan-2-yl-methane sulfonic acid and 37 g of potassium carbonate are added, and the temperature is raised to one hundred twenty ℃ until the reaction is completed. After cooling to room temperature, the reaction mixture was poured into 100 ml of water, extracted with ethyl acetate (100 ml of X3), and the organic layer was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to give 59 g of tert-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate as a white solid in 79% yield and 97% purity.
Example 3
28.8 g of 1, 3-difluoropropan-2-ol, 60.6 g of triethylamine and 300 ml of dichloromethane were added to a three-necked reaction flask with a stirrer, 41.2 g of methanesulfonyl chloride was added dropwise thereto, the mixture was reacted at zero degrees centigrade for one hour, and then the reaction mixture was poured into 200 ml of ice water, extracted with dichloromethane (100 ml of × 2), washed with one mole of hydrochloric acid at zero degrees centigrade to pH 2-3, washed with an organic layer (100 ml), washed with a saturated aqueous solution of sodium bicarbonate at zero degrees centigrade to pH 8-9, washed with an organic layer (100 ml), dried with anhydrous sodium sulfate, and concentrated under reduced pressure to obtain a colorless liquid 43.8 g of 1, 3-difluoropropan-2-yl-methanesulfonic acid with a yield of 87% and a purity of 98%.
55 g of raw material piperidine-4-carbamic acid tert-butyl ester is dissolved in 500 ml of dimethyl sulfoxide, 43.5 g of 1, 3-difluoropropan-2-yl-methane sulfonic acid and 38 g of potassium carbonate are added, and the temperature is raised to one hundred twenty ℃ until the reaction is completed. After cooling to room temperature, the reaction mixture was poured into 100 ml of water, extracted with ethyl acetate (100 ml of X3), and the organic layer was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to give 60 g of t-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate as a white solid in a yield of 80% and a purity of 97%.
Example 4
28.8 g of 1, 3-difluoropropan-2-ol, 60.6 g of triethylamine and 300 ml of dichloromethane are added into a three-neck reaction bottle with a stirrer, 41.2 g of methanesulfonyl chloride is added dropwise under zero centigrade, the mixture is reacted for one hour under zero centigrade, then the reaction mixture is poured into 200 ml of ice water, dichloromethane is used for extraction (100 ml of × 2), one mol of hydrochloric acid is used for washing an organic layer under zero centigrade till the pH value is 2-3, the organic layer is washed with water (100 ml), saturated aqueous sodium bicarbonate solution is used for washing the organic layer under zero centigrade till the pH value is 8-9, the organic layer is washed with water (100 ml), the organic layer is dried by anhydrous sodium sulfate and concentrated under reduced pressure to obtain colorless liquid 44 g of 1, 3-difluoropropan-2-yl-methanesulfonic acid, the yield is 88%, and the purity is 98%.
56 g of piperidine-4-carbamic acid tert-butyl ester serving as a raw material is dissolved in 500 ml of dimethyl sulfoxide, 44 g of 1, 3-difluoropropan-2-yl-methane sulfonic acid and 40 g of potassium carbonate are added, and the temperature is raised to one hundred twenty ℃ until the reaction is completed. After cooling to room temperature, the reaction mixture was poured into 100 ml of water, extracted with ethyl acetate (100 ml of X3), and the organic layer was dried over anhydrous sodium sulfate, concentrated, and subjected to column chromatography to give 61 g of t-butyl- (1- (1, 3-difluoropropan-2-yl) piperidin-4-yl) carbamate as a white solid in a yield of 80% and a purity of 97%.
Example 5
The following compounds were prepared:
Figure BDA0001185618860000051
wherein R is1=H,R2The starting material used in this example is benzyl:
Figure BDA0001185618860000052
wherein R1 ═ H and R2 ═ benzyl, instead of tert-butyl piperidine-4-carbamate in example 1, the amount of 1, 3-difluoropropan-2-ol used as the starting material was 5 times the amount used in example 1, and the amounts of the other reagents were 5 times the amounts used in example 1, and the remainder were the same as in example 1, and the final product yield was 83% and the purity was 98%.
Example 6
The following compounds were prepared:
Figure BDA0001185618860000053
wherein R is1Methyl, R2The starting material used in this example is benzyl:
Figure BDA0001185618860000054
wherein R is1Methyl, R2Instead of tert-butyl piperidine-4-carbamate in example 1, the amount of 1, 3-difluoropropan-2-ol used as the starting material was 3 times the amount used in example 1, the remaining reagents were 3 times the amount used in example 1, and the remainder was the same as in example 1, giving a final product with a yield of 81% and a purity of 97%.
The above description is only a preferred embodiment of the present invention, and it should be noted that, for those skilled in the art, several modifications and variations can be made without departing from the technical principle of the present invention, and these modifications and variations should also be regarded as the protection scope of the present invention.

Claims (7)

1. A compound having the following general formula I: a synthesis method of N-1, 3-difluoro isopropyl-4-amino piperidine compounds is characterized in that,
Figure FDA0002443440150000011
the method comprises the following steps: (1) dissolving 1, 3-difluoropropane-2-ol and alkali A in a solvent A, then dropwise adding methylsulfonyl chloride, and separating to obtain 1, 3-difluoropropane-2-yl-methanesulfonic acid;
(2) dissolving a compound shown in a general formula II in a solvent B, adding a base B and 1, 3-difluoropropane-2-yl-methanesulfonic acid, heating for reaction,
Figure FDA0002443440150000012
after the reaction is finished, separating and purifying to obtain the N-1, 3-difluoro isopropyl-4-aminopiperidine compound, wherein R is1,R2Each independently selected from: hydrogen, tert-butoxycarbonyl, C1-C8 alkyl, benzyl, 3-methyl-2-en-1-butyl, 2-methoxyethyl, 2-dimethylaminoethyl, 3-dimethylaminopropyl, cyclopropylmethyl, 2-cyclopropylethyl, 2-pyrrolylethyl, 2- (N-ethylpyrrol-2-yl) -ethyl, cyclopentyl, cyclohexyl, 3, 4-dimethoxyphenethyl.
2. The method for synthesizing N-1, 3-difluoroisopropyl-4-aminopiperidine compounds as claimed in claim 1, wherein R1 and R2 are independently selected from: hydrogen, tert-butoxycarbonyl.
3. The method for synthesizing an N-1, 3-difluoroisopropyl-4-aminopiperidine compound according to claim 1 or 2, wherein the base a is an organic base and the base B is an inorganic base.
4. The method for synthesizing an N-1, 3-difluoroisopropyl-4-aminopiperidine compound as claimed in claim 3, wherein the base A is triethylamine and the base B is potassium carbonate or sodium carbonate.
5. The method for synthesizing N-1, 3-difluoroisopropyl-4-aminopiperidine compounds according to claim 1 or 2, wherein the solvent A is dichloromethane and the solvent B is dimethylsulfoxide.
6. The method for synthesizing N-1, 3-difluoroisopropyl-4-aminopiperidine compounds according to claim 5, wherein the volume/weight ratio ml/g of the dichloromethane to the 1, 3-difluoropropan-2-ol is 3 to 10: 1; the volume-weight ratio ml/g of the dimethyl sulfoxide to the compound of the general formula II is 3-10: 1.
7. the method for synthesizing N-1, 3-difluoroisopropyl-4-aminopiperidine compounds according to claim 1 or 6, wherein the molar ratio of the added methanesulfonyl chloride to the 1, 3-difluoropropan-2-ol is 0.5 to 2.5: 1; the molar ratio of the added 1, 3-difluoropropane-2-ol to the compound of the general formula II is 0.5-2.5: 1.
CN201611183379.XA 2016-12-20 2016-12-20 Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound Active CN106674085B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201611183379.XA CN106674085B (en) 2016-12-20 2016-12-20 Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201611183379.XA CN106674085B (en) 2016-12-20 2016-12-20 Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound

Publications (2)

Publication Number Publication Date
CN106674085A CN106674085A (en) 2017-05-17
CN106674085B true CN106674085B (en) 2020-06-23

Family

ID=58869774

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201611183379.XA Active CN106674085B (en) 2016-12-20 2016-12-20 Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound

Country Status (1)

Country Link
CN (1) CN106674085B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111233751B (en) * 2020-03-25 2021-02-02 丽水绿氟科技有限公司 Preparation method of 3, 3-difluoro-4-aminopiperidine compound and derivative thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1487919A (en) * 2000-12-01 2004-04-07 New mandelic acid derivatives and their use as throbin inhibitors
CN103167867A (en) * 2010-10-29 2013-06-19 Abbvie公司 Solid dispersions containing an apoptosis-inducing agent
WO2016128465A1 (en) * 2015-02-11 2016-08-18 Basilea Pharmaceutica Ag Substituted mono- and polyazanaphthalene derivatives and their use

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1487919A (en) * 2000-12-01 2004-04-07 New mandelic acid derivatives and their use as throbin inhibitors
CN103167867A (en) * 2010-10-29 2013-06-19 Abbvie公司 Solid dispersions containing an apoptosis-inducing agent
WO2016128465A1 (en) * 2015-02-11 2016-08-18 Basilea Pharmaceutica Ag Substituted mono- and polyazanaphthalene derivatives and their use

Also Published As

Publication number Publication date
CN106674085A (en) 2017-05-17

Similar Documents

Publication Publication Date Title
CN104876995B (en) The preparation method of chenodeoxycholic acid derivatives
CN105968024A (en) Synthesis method of oxiracetam
CN105273025B (en) A kind of intermediate and its preparation method and application preparing cangrelor
CN103980336A (en) New fulvestrant synthesis method
CN105273026B (en) A kind of pharmaceutical intermediate and its preparation method and application
CN104177331B (en) The preparation method of bilastine
CN106674085B (en) Synthesis method of N-1, 3-difluoro isopropyl-4-aminopiperidine compound
CN105061405A (en) Preparation method of fimasartan potassium salt hydrate
JP5646706B2 (en) Method for producing C-glycoside derivative
CN101914052A (en) Oxiracetam compound and new method thereof
CN105273027B (en) Cangrelor intermediate and its preparation method and application
CN106478587A (en) A kind of synthetic method of ticagrelor intermediate
CN109928933B (en) 2-chloro-5-aldehyde pyrimidine and preparation method thereof
CN106631911A (en) Method for synthesizing cis-tritosylate
CN107501171B (en) Synthetic method of 2-chloro-3-pyridylaldehyde
CN107382785B (en) One seed sand library must bent key intermediate preparation method
CN106279008A (en) A kind of purifying process of sulfasalazine
CN104892491B (en) Method for synthesizing paroxetine chiral intermediate
CN104387435B (en) Compound and preparation method and application thereof
CN111116597A (en) Preparation method of nalbuphine free alkali
CN112759535B (en) Preparation method of PF-06651600 intermediate
CN110483319B (en) Preparation method of N-alkoxy oxalyl alanine ester
CN108250008A (en) 3,3,3`, 3`- tetramethyl -1,1`- spiro indan -6,6`- diol, derivatives chiral separation methods
CN101935317A (en) Synthesizing method of 2-methyl-7-(substituted pyrimidine-4-amino)-4-(substituted piperazine-1-base) piperidine-1-base) isoindoline-1-ketone and intermediate thereof
CN101723879A (en) Method for synthesizing (R)-3-ethyl piperidine hydrochloride

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
TR01 Transfer of patent right
TR01 Transfer of patent right

Effective date of registration: 20230506

Address after: No. 58 Haichuang Road, Haiyu Town, Changshu City, Suzhou City, Jiangsu Province, 215519

Patentee after: Changshu Hongde Biotechnology Co.,Ltd.

Address before: No. 208 Tongyuan Road, Industrial Park, Suzhou City, Jiangsu Province, 215006

Patentee before: SUZHOU HANDE CHUANGHONG BIOCHEMICAL TECHNOLOGY Co.,Ltd.